These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17228457)

  • 1. Co-infections. Fighting fatigue and depression in HCV/HIV co-infection.
    TreatmentUpdate; 2006; 18(1):2-3. PubMed ID: 17228457
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection fighters. Hepatitis C and HIV.
    TreatmentUpdate; 2005; 17(1):7. PubMed ID: 17225318
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of human immunodeficiency virus infection in patients infected with the hepatitis C virus.
    Valle Tovo C; Alves de Mattos A; Ribeiro de Souza A; Ferrari de Oliveira Rigo J; Lerias de Almeida PR; Galperim B; Riegel Santos B
    Liver Int; 2007 Feb; 27(1):40-6. PubMed ID: 17241379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-infections. Predicting recovery from hep C.
    TreatmentUpdate; 2008; 20(4):10-1. PubMed ID: 19248276
    [No Abstract]   [Full Text] [Related]  

  • 5. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
    TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
    [No Abstract]   [Full Text] [Related]  

  • 6. Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence.
    Taylor LE; Schwartzapfel B; Allen S; Jacobs G; Mitty J
    Clin Infect Dis; 2003 Jun; 36(11):1501-2; author reply 1502-3. PubMed ID: 12766851
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of HIV-HCV and HBV-HCV co-infection].
    Jmelnitzky AC; Jorge O; Manero E
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S46-8. PubMed ID: 20214301
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C co-infection review.
    Raymond D
    Posit Aware; 2004; 15(2):28-30, 33. PubMed ID: 15106528
    [No Abstract]   [Full Text] [Related]  

  • 9. Current issues in hepatitis C, HIV co-infection discussed at lunch and learn.
    Monarch A
    Surviv News (Atlanta Ga); 2002 Sep; ():14. PubMed ID: 12765135
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing hepatitis C infection in HIV-positive patients.
    Craven DE; Nunes DP
    AIDS Clin Care; 2000 Sep; 12(9):71-5, 78. PubMed ID: 12170952
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV/HCV coinfection exacerbates ESLD risk.
    Highleyman L
    IAPAC Mon; 2006 Sep; 12(9):329. PubMed ID: 17378068
    [No Abstract]   [Full Text] [Related]  

  • 12. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon?
    McGovern B; Bica I
    Clin Infect Dis; 2003 Aug; 37(3):463-4; author reply 464-5. PubMed ID: 12884180
    [No Abstract]   [Full Text] [Related]  

  • 13. Advisory panel: expand hepatitis therapy to HIV/AIDS patients.
    AIDS Policy Law; 2002 Jul; 17(12):2. PubMed ID: 12134793
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selection for treatment of hepatitis C co-infected patients for ].
    Findor J; Bessone F; Corti M
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S48-50; discussion S74-82. PubMed ID: 16862860
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV agents. Hepatitis C treatment and possible interactions with anti-HIV drugs.
    TreatmentUpdate; 2004; 16(3):2-4. PubMed ID: 17216833
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
    Bolcic F; Bull L; Martinez L; Reynoso R; Salomon H; Arduino R; Barnett B; Quarleri J
    Intervirology; 2008; 51(4):261-4. PubMed ID: 18824873
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006.
    Cacoub P; Halfon P; Rosenthal E; Pialoux G; Benhamou Y; Perronne C; Pol S;
    J Hepatol; 2008 Jan; 48(1):35-42. PubMed ID: 17945375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis complicating hepatitis C treatment in HIV-infected patients.
    Pérez-Elías MJ; García-San Miguel L; González García J; Montes Ramírez ML; Muriel A; Machín-Lázaro JM; Martínez-Baltanás A; Zamora F; Moreno A; Martín-Dávila P; Quereda C; Gómez-Mampaso E; Moreno S
    Clin Infect Dis; 2009 Apr; 48(8):e82-5. PubMed ID: 19275500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating hepatitis C virus in HIV patients: are side effects a real obstacle?
    Gatti F; Nasta P; Matti A; Manno D; Mendeni M; Puoti M; Carosi G
    AIDS Rev; 2007; 9(1):16-24. PubMed ID: 17474310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.